Meningococcal disease

Meningococcal disease is a rare, but potentially devastating infection. It is caused by the bacteria Neisseria meningitidis of which there are 6 disease-causing strains called serogroups (A, B, C, W, Y and X). Approximately 10 percent of the general population of the UK are thought to carry N. meningitidis in the lining of the nose and throat. Spread between individuals occurs through coughing, sneezing, kissing or during close contact with a carrier. Carriers do not have symptoms, but can develop disease when bacteria invade the bloodstream from the nasopharynx (area at the back of the nose and throat). Invasive disease is a rare but serious outcome usually presenting as septicaemia (blood poisoning) or meningitis (infection of the lining of the brain).

In most parts of the world meningococcal disease occurs as occasional cases in individuals or in small clusters. The disease is most common in the 'meningitis belt' of sub-Saharan Africa, which extends across the dry savannah regions from Senegal in the west, to Ethiopia in the east. These outbreaks occur particularly during the dry season and are most commonly caused by serogroup A. Following several large outbreaks associated with pilgrimage to the Kingdom of Saudi Arabia, all those travelling for the Hajj or Umrah are currently required to show proof of vaccination with quadrivalent vaccine (protecting against the A,C,W and Y serogroups) in order to obtain a visa.

Invasive meningococcal disease usually presents as meningitis or septicaemia. Symptoms of meningitis include: sudden onset of fever, intense headache, neck stiffness, nausea and vomiting. Symptoms of septicaemia include: fever, chills, confusion and a rash. Both conditions may progress rapidly and are serious diseases with high risk of complications and fatality.


Individuals should seek advice about their risk of meningitis prior to travel. Meningococcal disease in travellers is primarily a risk for those visiting areas prone to outbreaks or an area where a known outbreak is occurring. Travellers visiting such locations who are at particular risk include:

  • long stay travellers who have close contact with the local population
  • healthcare workers
  • those visiting friends and relatives
  • those who live or travel ‘rough’ such as backpackers
  • individuals with no spleen or a poorly functioning spleen
  • individuals with certain immune deficiencies

Meningitis vaccines

Meningococcal vaccinations are administered as part of the routine NHS vaccination schedule. Meningococcal group C vaccination was the first meningococcal vaccination to be added to the schedule in 1999. Both meningococcal group B (Bexsero®) and the quadrivalent meningococcal vaccine (protective against serogroups A,C,W and Y) will be offered to children from Autumn 2015Travellers visiting higher risk regions are recommended to have the conjugate ACWY vaccine (Menveo® or Nimenrix®) if their planned activities put them at increased risk (see above).




The National Travel Health Network and Centre (NaTHNaC) is commissioned by Public Health England to provide health information for both healthcare professionals and travellers. Information is compiled by the NaTHNaC clinical and scientific team, and updated regularly. Further advice on health risks and disease outbreaks is available at

Date last reviewed: November 2015

Read these next

Plans to alter routine childhood immunisation schedule announced

Plans to alter routine childhood immunisation schedule announced

From 1st July 2016, infants will no longer receive...

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.